more_reports

The Latest Healthcare Services Articles from Streetwise Reports

Clean Tech Developer Sees Massive Opportunity in PFAS Treatment

  ()
BioLargo Inc. (BLGO:OTCQX) announces that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been installed in New Jersey. Find out why the company sees massive upside for its products.

Environmental Firm Finds High-Value Position in PFAS Remediation Industry

  ()
BioLargo Inc. (BLGO:OTCQX) has announced the installation of its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system in New Jersey. Discover why the company anticipates significant potential for its products.

Strategic Inflection: Scaling Multi-Condition Platform in Financial Transition

  ()
Current valuation disproportionately penalizes DarioHealth for balance sheet constraints while assigning negligible value to its contracted growth and superior margin profile. As the revenue from the 2025 bookings cohort begins to layer in during the first half of 2026, we anticipate a re-rating of the equity toward multiples consistent with its high-growth digital health peers.

Tech Firm Partners to Advance AI-Powered Support for MDs

  ()
Rocket Doctor AI Inc.'s (AIDR:CSE; TREIF:OTC; 939:FRA) Clinical Decision Support System is being deployed in Alberta, Canada, on a small scale for a trial period with the goal of expanding it province-wide next year. This company's stock is rated Speculative Buy; read on to learn why.

Clean Tech Co.: Wound Care Subsidiary Set to Take Off; 3Q Results

  ()
Clean technology innovation company BioLargo Inc. releases its financial and operational results for the three- and nine-month periods ending September 30. It also has announced an agreement to distribute its cutting-edge wound irrigation solution nationally.

AI Cancer Discovery Shows Breakthrough in Brain-Targeting Treatment

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) is set to unveil new preclinical data from its AI-driven ATR inhibitor program at a major international cancer conference in Boston. The findings highlight strong efficacy and blood-brain barrier permeability, a potential breakthrough for hard-to-treat tumors and brain metastases.

Healthcare Tech Firm Finds Big U.S. Opportunity

  ()
Healthcare data firm OneMedNet Corporation (Nasdaq: ONMD) partners with Palantir Technologies Inc. (PLTR:NASDAQ) to analyze over 5 billion claims and 131 million exams, unlocking a possible massive U.S. breakthrough in AI-driven research.

Biotech Firm Uncovers Breakthrough Gene Therapy in New York

  ()
Lexeo Therapeutics Inc. (LXEO:NASDAQ) advanced its LX2006 program after new FDA feedback supported an accelerated approval path. Read how interim data showed strong cardiac and neurological improvements, prompting bullish analyst upgrades.

Clean Tech Co.'s 'Forever Chemical' Solution Is a PFAS Breakthrough

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announced compelling new findings about its proprietary Aqueous Electrostatic Concentration (AEC) "forever chemicals" solution. Read to discover why one expert thinks the breakthrough is important to the company's future.

Healthcare AI Company Rebrands as Rocket Doctor AI to Pursue Growing Market Opportunities

  ()
Treatment.com AI Inc. has rebranded and reincorporated as Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) to reflect the integration of its proprietary AI-driven Global Library of Medicine (GLM) with the recently acquired Rocket Doctor Inc. Read why one analyst calls part of the company's offerings "Shopify for physicians."

Showing Results: 1 to 10 of 10